Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
2011

Antifungal Activity of Synthetic Arylquinuclidine Derivatives Against Candida Species

Sample size: 64 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ishida Kelly, Fernandes Rodrigues Juliany Cola, Cammerer Simon, Urbina Julio A, Gilbert Ian, de Souza Wanderley, Rozental Sonia

Primary Institution: Universidade Federal do Rio de Janeiro

Hypothesis

The study aims to evaluate the antifungal activity of squalene synthase inhibitors on various Candida strains.

Conclusion

Arylquinuclidine derivatives could be useful as lead compounds for the rational synthesis of new antifungal drugs.

Supporting Evidence

  • WSP1267 showed a MIC50 of 2 μg/ml for all species tested.
  • Ultrastructural alterations were observed in C. albicans treated with WSP1267.
  • Fluorescence microscopy revealed lipid accumulation in treated yeasts.
  • Treatment with WSP1267 caused significant changes in the cell cycle of C. albicans.
  • All isolates resistant to fluconazole were susceptible to WSP1267.

Takeaway

Scientists tested new compounds to see if they could stop yeast infections caused by Candida, and found one that works really well.

Methodology

Ten arylquinuclidines were tested against three ATCC strains and 54 clinical isolates of Candida, with morphological alterations evaluated by microscopy.

Limitations

The study primarily focused on one derivative and its effects on a limited number of strains.

Participant Demographics

The study included 54 clinical isolates of Candida from patients, with specific strains identified.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-0711-10-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication